Chicago Equity Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-33,695
Closed -$2.9M – 947
2019
Q2
$2.9M Buy
33,695
+5,445
+19% +$371K 0.13% 225
2019
Q1
$1.67M Buy
+28,250
New +$1.62M 0.06% 389
2017
Q4
– Sell
-29,215
Closed -$1.12M – 815
2017
Q3
$1.12M Buy
+29,215
New +$1.22M 0.04% 493
2016
Q4
– Sell
-13,750
Closed -$415K – 786
2016
Q3
$415K Buy
+13,750
New +$415K 0.01% 592

Other funds holding RGEN

Chicago Equity Partners's RGEN Position: Q3 2019 in Review

Chicago Equity Partners sold out of Repligen (RGEN) in Q3 2019, closing a stake of 33,695 shares — an estimated $2.9M sold.

Chicago Equity Partners first reported a position in RGEN in Q3 2016 and held it in 4 quarters. The position peaked at $2.9M in Q2 2019. 303 funds tracked by Wall St. Rank hold RGEN as of Q3 2019.

  • Chicago Equity Partners reported no remaining Repligen position as of Q3 2019 after selling out during the quarter.
  • Chicago Equity Partners sold 33,695 Repligen shares in Q3 2019, an estimated $2.9M.
  • Chicago Equity Partners first reported a position in Repligen in Q3 2016 and held it in 4 quarters.
  • Chicago Equity Partners's Repligen position peaked at $2.9M in Q2 2019.
  • 303 funds tracked by Wall St. Rank held Repligen as of Q3 2019.

Based on Chicago Equity Partners's 13F filing for Q3 2019, filed 30 Oct 2019.